Expression and effects of inhibition of type I insulin-like growth factor receptor tyrosine kinase in mantle cell lymphoma

od Vishwamitra, Deeksha, Shi, Ping, Wilson, Desiree, Manshouri, Roxsan, Vega, Francisco, Schlette, Ellen J., Amin, Hesham M.
Wydane 2011

p53 Expression by Immunohistochemistry is an Independent Determinant of Survival in Chronic Lymphocytic Leukemia Patients Receiving Frontline Chemo-Immunotherapy

od Schlette, Ellen J, Admirand, Joan, Wierda, William, Abruzzo, Lynne, O'Brien, Susan, Lerner, Susan, Keating, Michael J, Tam, Constantine
Wydane w Leuk Lymphoma (2009)

Immunohistochemical detection of ZAP70 in chronic lymphocytic leukemia predicts immunoglobulin heavy chain gene mutation status and time to progression

od Admirand, Joan H., Knoblock, Ronald J., Coombes, Kevin R., Tam, Constantine, Schlette, Ellen J., Keating, Michael J., Luthra, Rajyalakshmi, Medeiros, L. Jeffrey, Abruzzo, Lynne V.
Wydane 2010

Expression of serine 194–phosphorylated Fas-associated death domain protein correlates with proliferation in B-cell non–Hodgkin lymphomas

od Drakos, Elias, Leventaki, Vasiliki, Atsaves, Vasileios, Schlette, Ellen J., Lin, Pei, Vega, Francisco, Miranda, Roberto N., Claret, Francois-Xavier, Medeiros, L. Jeffrey, Rassidakis, George Z.
Wydane 2011

mTOR signaling is activated by FLT3 kinase and promotes survival of FLT3-mutated acute myeloid leukemia cells

od Chen, Weina, Drakos, Elias, Grammatikakis, Ioannis, Schlette, Ellen J, Li, Jiang, Leventaki, Vasiliki, Staikou-Drakopoulou, Efi, Patsouris, Efstratios, Panayiotidis, Panayiotis, Medeiros, L Jeffrey, Rassidakis, George Z
Wydane 2010

Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia

od Ferrajoli, Alessandra, Lee, Bang-Ning, Schlette, Ellen J., O'Brien, Susan M., Gao, Hui, Wen, Sijin, Wierda, William G., Estrov, Zeev, Faderl, Stefan, Cohen, Evan N., Li, Changping, Reuben, James M., Keating, Michael J.
Wydane 2008

Correlation between FDG/PET, histology, characteristics, and survival in 332 patients with chronic lymphoid leukemia

od Falchi, Lorenzo, Keating, Michael J., Marom, Edith M., Truong, Mylene T., Schlette, Ellen J., Sargent, Rachel L., Trinh, Long, Wang, Xuemei, Smith, Susan C., Jain, Nitin, Estrov, Zeev, O’Brien, Susan, Wierda, William G., Lerner, Susan, Ferrajoli, Alessandra
Wydane 2014

Achieving complete remission in CLL patients treated with ibrutinib: clinical significance and predictive factors

od Strati, Paolo, Schlette, Ellen J., Solis Soto, Luisa M., Duenas, Daniela E., Sivina, Mariela, Kim, Ekaterina, Keating, Michael J., Wierda, William G., Ferrajoli, Alessandra, Kantarjian, Hagop, Estrov, Zeev, Jain, Nitin, Thompson, Philip A., Wistuba, Ignacio I., Burger, Jan A.
Wydane w Blood (2020)

Whole-Genome Scanning by Array Comparative Genomic Hybridization as a Clinical Tool for Risk Assessment in Chronic Lymphocytic Leukemia

od Gunn, Shelly R., Mohammed, Mansoor S., Gorre, Mercedes E., Cotter, Philip D., Kim, Jaeweon, Bahler, David W., Preobrazhensky, Sergey N., Higgins, Russell A., Bolla, Aswani R., Ismail, Sahar H., de Jong, Daphne, Eldering, Eric, van Oers, Marinus H.J., Mellink, Clemens H.M., Keating, Michael J., Schlette, Ellen J., Abruzzo, Lynne V., Robetorye, Ryan S.
Wydane 2008

A proposal for pathologic processing of breast implant capsules in patients with suspected breast implant anaplastic large cell lymphoma

od Lyapichev, Kirill A., Piña-Oviedo, Sergio, Medeiros, L. Jeffrey, Evans, Mark G., Liu, Hui, Miranda, Alonso R., Hunt, Kelly K., Clemens, Mark W., Stewart, John M., Amin, Mitual B., Quesada, Andres E., Chai, Siaw Ming, Napoli, Arianna Di, Yoga, Arthy, Dave, Sanat K., Wistuba, Ignacio I., Wu, Yun, Bueso-Ramos, Carlos E., Schlette, Ellen J., Ferrufino-Schmidt, Maria C., Loghavi, Sanam, Khoury, Joseph D., Young, Ken H., Miranda, Roberto N.
Wydane w Mod Pathol (2019)